Latest filingSep 04, 2026Most recent Form 4
CBLL
Ceribell, Inc.
NasdaqHealthcareElectromedical & Electrotherapeutic Apparatus
Insider activity for last month from 08/05 to 09/05. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$269M6 sells
Net open-market-$269M2 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period24transactions
- M · Option exercise · dominant18 · 75%
- S · Open-market sells6 · 25%
Activity by reported role
A joint filing can contribute to multiple roles24transactions
- Chief financial officer · dominant13 · 54%
- PRES11 · 46%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (2)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeBlumberg ScottCommon Stock · Direct
147,252Sep 02, 2026
Chao XingjuanCommon Stock · Direct
783,177Sep 02, 2026
Blumberg ScottStock Option (Right to Buy) · Direct
52,648Sep 02, 2026
Chao XingjuanStock Option (Right to Buy) · Direct
30,815Sep 02, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 05 → Sep 05
LessMore
Top insiders
By absolute net value across the selected period- CX-$1.8M
- BS-$879.9k
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
CBLL transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| CBLL | Chao Xingjuan | PRES | sale10b5-1 | 39.5k | -$97.3M | S | — | 0.0% | 09/04 | 09/02 |
| CBLL | Blumberg Scott | CFO | sale10b5-1 | 652 | -$1.63M | S | — | 0.0% | 09/04 | 09/02 |
| CBLL | Blumberg Scott | CFO | sale10b5-1 | 33.5k | -$83.8M | S | +1.6% | 08/21 | 08/19 | |
| CBLL | Blumberg Scott | CFO | sale10b5-1 | 990 | -$2.47M | S | +1.6% | 08/21 | 08/18 | |
| CBLL | Chao Xingjuan | PRES | sale10b5-1 | 31.4k | -$78.6M | S | +1.2% | 08/20 | 08/19 | |
| CBLL | Chao Xingjuan | PRES | sale10b5-1 | 2.19k | -$5.49M | S | +1.2% | 08/20 | 08/18 |
Ceribell, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Ceribell, Inc.?
Chao Xingjuan, Blumberg Scott.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Chao Xingjuan reported a sale on Sep 02, 2026 valued at $97.3M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $2,694,227.21. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.